Affiliation:
1. National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Abstract
ABSTRACT
Resistance to rifampin in
Mycobacterium tuberculosis
results from mutations in the gene coding for the beta subunit of RNA polymerase (
rpoB
). At least 95% of rifampin-resistant isolates have mutations in
rpoB
, and the mutations are clustered in a small region. About 40 distinct point mutations and in-frame insertions and deletions in
rpoB
have been identified, but point mutations in two codons, those coding for Ser
531
and His
526
, are seen in about 70% of rifampin-resistant clinical isolates, with Ser
531
-to-Leu (TCG-to-TGG) mutations being by far the most common. To explore this phenomenon, we isolated independent, spontaneous, rifampin-resistant mutant versions of well-characterized
M. tuberculosis
laboratory strain H37Rv by plating 100 separate cultures, derived from a single low-density inoculum, onto rifampin-containing medium. Rifampin-resistant mutants were obtained from 64 of these cultures. Although we anticipated that the various point mutations would occur with approximately equal frequencies, sequencing the
rpoB
gene from one colony per plate revealed that 39 (60.9%) were Ser
531
to Leu. We conclude that, for unknown reasons, the associated
rpoB
mutation occurs at a substantially higher rate than other
rpoB
mutations. This higher mutation rate may contribute to the high percentage of this mutation seen in clinical isolates.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献